Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_assertion type Assertion NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_head.
- NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_assertion description "[The lymphoma lesion additionally harbored CD3(+) CD25(+) activated normal T cells despite ongoing tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_provenance.
- NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_assertion evidence source_evidence_literature NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_provenance.
- NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_assertion SIO_000772 11423937 NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_provenance.
- NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_assertion wasDerivedFrom befree-2016 NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_provenance.
- NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_assertion wasGeneratedBy ECO_0000203 NP321911.RA-ibVCWt0hCIh-2F5eEcB-nIQUw3Xm0L53pVp3WnCidU130_provenance.